SLC2A13 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $48.00 $122.00 $432.00 $812.00 | 4 | |
WZB117 is known to inhibit GLUT1, a glucose transporter protein. As SLC2A13 belongs to the same transporter family, WZB117 can inhibit SLC2A13 by hindering the glucose transport across the cell membrane, thereby decreasing the glucose influx that SLC2A13 normally mediates. | ||||||
STF 31 | 724741-75-7 | sc-364692 | 10 mg | $183.00 | 3 | |
STF-31 is a selective inhibitor of GLUT1. Its mechanism involves the obstruction of the glucose binding site on GLUT1. Since SLC2A13 is structurally similar to GLUT1 as part of the SLC2A transporter family, STF-31 can inhibit SLC2A13 by a similar mechanism, targeting the glucose binding domain. | ||||||
Cytochalasin B | 14930-96-2 | sc-3519 | 5 mg | $195.00 | 19 | |
Cytochalasin B acts by binding to the glucose transporter and blocking the sugar transport channel. This inhibition of glucose transport can extend to SLC2A13 by blocking its ability to translocate glucose across the cell membrane. | ||||||
BAY-876 | 1799753-84-6 | sc-507539 | 5 mg | $240.00 | ||
BAY-876 is a specific inhibitor of GLUT1. By occupying the binding sites of GLUT1, it can likewise inhibit SLC2A13 by competitive inhibition, preventing glucose from entering the binding pocket necessary for its transport function. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $32.00 $210.00 $720.00 $1128.00 $2302.00 $3066.00 $5106.00 | 22 | |
Apigenin, a flavone found in many plants, is known to inhibit glucose uptake by SLC2A transporters. It can inhibit SLC2A13 by binding to the extracellular part of the transporter, thus altering its conformation and impairing its glucose transport ability. | ||||||
Fasentin | 392721-37-8 | sc-215012 sc-215012A | 5 mg 25 mg | $125.00 $440.00 | ||
Fasentin interferes with the intracellular trafficking of glucose transporters. This could inhibit SLC2A13 by preventing its proper localization in the cell membrane, thereby reducing its glucose transport capacity. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin is a flavonoid that inhibits glucose transporters by interfering with their trafficking and membrane localization. It can inhibit SLC2A13 by similar mechanisms, therefore reducing the functional presentation of SLC2A13 on the cell surface. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is an isoflavone that has been shown to inhibit the activity of various members of the SLC2A family by altering their transport function. This inhibition likely extends to SLC2A13, as Genistein could alter its glucose transport capacity by binding to the transporter or modifying its function through phosphorylation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol is a polyphenolic compound that can inhibit glucose transporters. This inhibition of SLC2A13 could occur through the alteration of the conformation of the transporter, impeding its ability to facilitate the passage of glucose molecules. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $26.00 $50.00 $99.00 $150.00 $1887.00 | 40 | |
Luteolin is a flavonoid known to inhibit glucose uptake by SLC2A transporters. It may inhibit SLC2A13 by binding to the transporter and blocking the glucose binding site, thus preventing its normal function in glucose transport. | ||||||